Ritchie DS - Search Results

1

Immunosurveillance and therapy of multiple myeloma are CD226 dependent.

Guillerey C, Ferrari de Andrade L, Vuckovic S, Miles K, Ngiow SF, Yong MC, Teng MW, Colonna M, Ritchie DS, Chesi M, Bergsagel PL, Hill GR, Smyth MJ, Martinet L. Guillerey C, et al. Among authors: ritchie ds. J Clin Invest. 2015 May;125(5):2077-89. doi: 10.1172/JCI77181. Epub 2015 Apr 20. J Clin Invest. 2015. PMID: 25893601 Free PMC article.

2

Patients with multiple myeloma treated with thalidomide: evaluation of clinical parameters, cytokines,angiogenic markers, mast cells and marrow CD57+ cytotoxic T cells as predictors of outcome.

Mileshkin L, Honemann D, Gambell P, Trivett M, Hayakawa Y, Smyth M, Beshay V, Ritchie D, Simmons P, Milner AD, Zeldis JB, Prince HM. Mileshkin L, et al. Haematologica. 2007 Aug;92(8):1075-82. doi: 10.3324/haematol.11208. Epub 2007 Jul 20. Haematologica. 2007. PMID: 17640854 Free article.

3

A new therapeutic target for leukemia comes to the surface.

Ritchie DS, Smyth MJ. Ritchie DS, et al. Cell. 2009 Jul 23;138(2):226-8. doi: 10.1016/j.cell.2009.07.005. Cell. 2009. PMID: 19632173 Free article.

4

Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma.

Quach H, Ritchie D, Stewart AK, Neeson P, Harrison S, Smyth MJ, Prince HM. Quach H, et al. Leukemia. 2010 Jan;24(1):22-32. doi: 10.1038/leu.2009.236. Epub 2009 Nov 12. Leukemia. 2010. PMID: 19907437 Free PMC article. Review.

5

Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigen.

Peinert S, Prince HM, Guru PM, Kershaw MH, Smyth MJ, Trapani JA, Gambell P, Harrison S, Scott AM, Smyth FE, Darcy PK, Tainton K, Neeson P, Ritchie DS, Hönemann D. Peinert S, et al. Among authors: ritchie ds. Gene Ther. 2010 May;17(5):678-86. doi: 10.1038/gt.2010.21. Epub 2010 Mar 4. Gene Ther. 2010. PMID: 20200563

6

Ex vivo culture of chimeric antigen receptor T cells generates functional CD8+ T cells with effector and central memory-like phenotype.

Neeson P, Shin A, Tainton KM, Guru P, Prince HM, Harrison SJ, Peinert S, Smyth MJ, Trapani JA, Kershaw MH, Darcy PK, Ritchie DS. Neeson P, et al. Among authors: ritchie ds. Gene Ther. 2010 Sep;17(9):1105-16. doi: 10.1038/gt.2010.59. Epub 2010 Apr 29. Gene Ther. 2010. PMID: 20428216

7

Biology and clinical observations of regulatory T cells in cancer immunology.

Teng MW, Ritchie DS, Neeson P, Smyth MJ. Teng MW, et al. Among authors: ritchie ds. Curr Top Microbiol Immunol. 2011;344:61-95. doi: 10.1007/82_2010_50. Curr Top Microbiol Immunol. 2011. PMID: 20512555 Review.

8

Alloreactive natural killer cells in hematopoietic stem cell transplantation.

Pegram HJ, Ritchie DS, Smyth MJ, Wiernik A, Prince HM, Darcy PK, Kershaw MH. Pegram HJ, et al. Among authors: ritchie ds. Leuk Res. 2011 Jan;35(1):14-21. doi: 10.1016/j.leukres.2010.07.030. Epub 2010 Aug 16. Leuk Res. 2011. PMID: 20719383 Review.

9

The immunostimulatory effect of lenalidomide on NK-cell function is profoundly inhibited by concurrent dexamethasone therapy.

Hsu AK, Quach H, Tai T, Prince HM, Harrison SJ, Trapani JA, Smyth MJ, Neeson P, Ritchie DS. Hsu AK, et al. Among authors: ritchie ds. Blood. 2011 Feb 3;117(5):1605-13. doi: 10.1182/blood-2010-04-278432. Epub 2010 Oct 26. Blood. 2011. PMID: 20978269 Free article.

10

The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions.

Chan CJ, Martinet L, Gilfillan S, Souza-Fonseca-Guimaraes F, Chow MT, Town L, Ritchie DS, Colonna M, Andrews DM, Smyth MJ. Chan CJ, et al. Among authors: ritchie ds. Nat Immunol. 2014 May;15(5):431-8. doi: 10.1038/ni.2850. Epub 2014 Mar 23. Nat Immunol. 2014. PMID: 24658051

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

135 results

Search Page